Sort
11,323 grants matching “glioblastoma”
Characterization of a novel invasion-related gene in Glioblastoma
$0David C Adamson · Durham Va Medical Center · I01 · FY2011 · VA
Nanoplatform Delivery of MDA-7 and Brachytherapy for Treatment of Brain Tumors
$0Michael D Shultz · Va Veterans Administration Hospital · IK2 · FY2017 · VA
MARIMASTAT IN PATIENTS W/ GLIOBLASTOMA MULTIFORME OR GLIOSARCOMA
$0University Of Pennsylvania · M01 · FY2000 · RR
GENE THERAPY FOR BRAIN TUMORS USING ANTISENSE CDNA TRANSCRIPTION GROW
$0Case Western Reserve University · M01 · FY2002 · RR
SU101 VERSUS PROCARBAZINE FOR FIRST RELAPSE PATIENTS W/ GLIOBLASTOMA
$0University Of Michigan At Ann Arbor · M01 · FY2002 · RR
Nanoplatform Delivery of MDA-7 and Brachytherapy for Treatment of Brain Tumors
$0Michael D Shultz · Va Veterans Administration Hospital · IK2 · FY2015 · VA
Cellular Mechanisms Of Xenobiotic Transport
$0Environmental Health Sciences · Z01 · FY2003 · ES
GENE THERAPY FOR BRAIN TUMORS USING ANTISENSE CDNA TRANSCRIPTION GROW
$0Case Western Reserve University · M01 · FY2001 · RR
Molecular Pathogenesis
$0Neurological Disorders And Stroke · Z01 · FY2003 · NS
Delivery issues in lung cancer CNS metastases
$0Edward A Neuwelt · Portland Va Medical Center · I01 · FY2012 · VA
Phase II study of SU101 for patients with anaplastic ast
$0University Of Michigan At Ann Arbor · M01 · FY2002 · RR
TNT-1B IN ANAPLASTIC ASTROCYTOMA &GLIOBLASTOMA MULTIFORME
$0Medical University Of South Carolina · M01 · FY2001 · RR
TNT-1B IN ANAPLASTIC ASTROCYTOMA &GLIOBLASTOMA MULTIFORME
$0Medical University Of South Carolina · M01 · FY2001 · RR
Thrombin Cleavage of Osteopontin Suppresses Host-Anti-Tumor Immune Response in Cancer
$0Lawrence L Leung · Veterans Admin Palo Alto Health Care Sys · I01 · FY2022 · VA
TNT-1B IN ANAPLASTIC ASTROCYTOMA &GLIOBLASTOMA MULTIFORME
$0Medical University Of South Carolina · M01 · FY2001 · RR
Role of EphA2 RTK in tumor resistance to EGFR/HER2 inhibitors
$0Jin Chen · Veterans Health Administration · I01 · FY2012 · VA
PRE-IRRADIATION 9-AMINO-20(S)-CAMPTOTHECIN IN GLIOBLASTO
$0University Of Pennsylvania · M01 · FY2000 · RR
Monoclonal antibody inhibition of thrombin cleavage of osteopontin as a novel therapeutic to enhance host antitumor immunity and reduce cardiac fibrosis
$0Lawrence L Leung · Veterans Admin Palo Alto Health Care Sys · I01 · FY2024 · VA
PRE-IRRADIATION 9-AMINO-20(S)-CAMPTOTHECIN IN GLIOBLASTO
$0University Of Pennsylvania · M01 · FY2000 · RR
Imaging tumor progression &metastasis caused by deletion of PTEN
$0University Of California Los Angeles · P50 · FY2002 · CA
SU101 VS PROCARBAZINE FOR GLIOBLASTOMA MULTIFORME IN FIRST RELAPSE
$0Indiana Univ-Purdue Univ At Indianapolis · M01 · FY2000 · RR
SU101 VS PROCARBAZINE FOR GLIOBLASTOMA MULTIFORME IN FIRST RELAPSE
$0Indiana Univ-Purdue Univ At Indianapolis · M01 · FY2000 · RR
SU101 VS PROCARBAZINE FOR GLIOBLASTOMA MULTIFORME IN FIRST RELAPSE
$0Indiana Univ-Purdue Univ At Indianapolis · M01 · FY2000 · RR
PHASE II STUDY TO EVALUATE RSR13 THERAPY WITH RADIATION FOR GLIOBLASTOMA
$0Northwestern University · M01 · FY2001 · RR
SU101 VS PROCARBAZINE FOR GLIOBLASTOMA MULTIFORME IN FIRST RELAPSE
$0Indiana Univ-Purdue Univ At Indianapolis · M01 · FY2000 · RR